Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).
D000328:Adult; D000368:Aged; D000588:Amines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D002712:Chlorides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007962:Leukocytes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010984:Platinum / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D013936:Thymidine / Q000037:antagonists & inhibitors; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000588:Amines; D000970:Antineoplastic Agents; D002712:Chlorides; D004273:DNA, Neoplasm; D010984:Platinum; D013936:Thymidine